| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/12/2000 | US6117454 Loading a nanoparticle with a drug, coating with polyoxyethylene glycol, sorbitan monosteare or monooleate, or monolaurate, or monopalmitate, administering to the mammal in such a manner which allows it to enter the bloodstream |
| 09/12/2000 | US6117453 A tablet consists of a drug selected from acyclovir, nifedipine, nicardipine, captopril, verapamil, diltiazem, oxybutynine, valacyclovir, glipizide, felodipine, isosorbide, carbidopa, lavodopa, pentoxiphylline; and polyethylene oxide |
| 09/12/2000 | US6117452 A thermoformed particulates of active agents containing drugs or foods, processing aids consististing of glyceryl monostearate, polyoxyethylene glycol(32) glyceryl palmitostearate; comestible units |
| 09/12/2000 | US6117451 Direct compression metformin hydrochloride tablets |
| 09/12/2000 | US6117450 Selecting a predetermined number of at least three of four compressed compositions containing an effective ingredient or combination defined by their release |
| 09/12/2000 | US6117449 A liposomal preparation comprising lyophilized liposomes containing at least one antigen selected from the group consisting of hepatitis b and hepatitis c antigens and mixtures, and liposomes have atleast three different sizes |
| 09/12/2000 | US6117448 Consists of a layer of backing material which is substantially impermeable to nicotine and a matrix of nicotine in a body of pressure sensitive acrylate copolymer which is laminated to a protective layer, used for transdermal drug delivery |
| 09/12/2000 | US6117447 Percutaneous absorption type preparation |
| 09/12/2000 | US6117446 A buccal dosage unit for administering a combination of steroidal active agents, comprising a compressed tablet of a bioerodible polymeric carrier and an androgenic agent selected from testosterone and esters, progestin and esterogen |
| 09/12/2000 | US6117443 Needle-less parenteral introduction device |
| 09/12/2000 | US6117442 A core comprising androgen as a therapeutical agent and an elastomeric membrane encasing the core comprising polysiloxane containing 3,3,3 trifluoropropylgroup attached to silicon atom of siloxane unit |
| 09/12/2000 | US6117441 Silicone core long term androgen delivery implant |
| 09/12/2000 | US6117437 A deformable, sheet-like pharmaceutical form which delivers active substance, is coherent and is designed to be in its sheet-like extent equal to or smaller than the wound area to be managed and contains the drug homogenously dispersed |
| 09/12/2000 | US6117433 Use of compositions comprising stabilized biologically effective compounds |
| 09/12/2000 | US6117430 Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same |
| 09/12/2000 | US6117119 Gelatinous body protection article having a therapeutic additive |
| 09/12/2000 | US6116468 Arrangement and method for dispensing preservative-free nasal sprays and similar preparations |
| 09/12/2000 | US6116237 Methods of dry powder inhalation |
| 09/12/2000 | CA2212794C Oil in water emulsions containing propofol and edetate |
| 09/12/2000 | CA2064476C Podophyllotoxin preparation containing triglycerides |
| 09/12/2000 | CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them |
| 09/12/2000 | CA2020209C Low viscosity, highly concentrated surfactant suspension |
| 09/11/2000 | CA2276066A1 Microparticles for delivery of nucleic acid |
| 09/08/2000 | WO2000052149A1 Introducing a biological material into a patient |
| 09/08/2000 | WO2000052078A1 Use of protein conformation for the protection and release of chemical compounds |
| 09/08/2000 | WO2000052053A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | WO2000052049A2 A method for purifying human growth hormone |
| 09/08/2000 | WO2000052042A1 Immunogenic compounds |
| 09/08/2000 | WO2000051724A1 Method for protecting and/or controlled release of active ingredients |
| 09/08/2000 | WO2000051718A1 Chemical method for making pyrithione particle dispersions |
| 09/08/2000 | WO2000051629A1 Preparations stabilized over long time |
| 09/08/2000 | WO2000051619A1 Mucin containing ophthalmic preparations |
| 09/08/2000 | WO2000051603A2 Compositions of remifentanil |
| 09/08/2000 | WO2000051602A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 09/08/2000 | WO2000051593A2 Oral drug delivery system |
| 09/08/2000 | WO2000051591A1 Combinations of formoterol and mometasone furoate for asthma |
| 09/08/2000 | WO2000051582A2 Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| 09/08/2000 | WO2000051575A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 09/08/2000 | WO2000051574A1 Chewable soft capsule |
| 09/08/2000 | WO2000051573A1 Gum acacia substituted soft gelatin capsules |
| 09/08/2000 | WO2000051572A1 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| 09/08/2000 | WO2000051571A2 Capsule system |
| 09/08/2000 | WO2000051570A1 Chewable soft capsules having improved administration properties and process for producing the same |
| 09/08/2000 | WO2000051569A1 A method and a device for enclosing application of a coating on a tablet, capsule, pill or the like |
| 09/08/2000 | WO2000051568A1 Orally dispersible tablet with low friability and method for preparing same |
| 09/08/2000 | WO2000051567A1 Processes for making pharmaceutical oral ecb formulations and compositions |
| 09/08/2000 | WO2000051565A1 Encapsulation of bioactive complexes in liposomes |
| 09/08/2000 | WO2000051564A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 09/08/2000 | WO2000051563A1 Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter |
| 09/08/2000 | WO2000051549A1 Dermatological compositions containing a liquid crystal vehicle and method of preparing same |
| 09/08/2000 | WO2000051539A1 Opioid agonist in a fast dispersing dosage form |
| 09/08/2000 | WO2000051428A1 Compositions for aquatic contained in a microparticulate or nanoparticulate vector |
| 09/08/2000 | WO2000025754A3 Solid oral dosage forms containing alginic acid and famotidine |
| 09/08/2000 | WO2000023592B1 Minimal promoters and uses thereof |
| 09/08/2000 | WO2000020017A3 Controlled-release garlic formulations |
| 09/08/2000 | WO2000010526A3 New oral formulation for 5-ht4 agonists or antagonists |
| 09/08/2000 | CA2371822A1 Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| 09/08/2000 | CA2367042A1 Use of protein conformation for the protection and release of chemical compounds |
| 09/08/2000 | CA2366852A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 09/08/2000 | CA2364463A1 Introducing a biological material into a patient |
| 09/08/2000 | CA2364030A1 A method for purifying human growth hormone |
| 09/08/2000 | CA2363983A1 Chemical method for making pyrithione particle dispersions |
| 09/08/2000 | CA2363954A1 Immunogenic compounds |
| 09/08/2000 | CA2363592A1 Oral drug delivery system |
| 09/08/2000 | CA2362840A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | CA2362554A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 09/08/2000 | CA2362498A1 Mucin containing ophthalmic preparations |
| 09/08/2000 | CA2362485A1 Encapsulation of bioactive complexes in liposomes |
| 09/08/2000 | CA2362482A1 Processes for making pharmaceutical oral ecb formulations and compositions |
| 09/08/2000 | CA2362480A1 Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter |
| 09/07/2000 | DE19929647A1 Nifedipine pellets providing both rapid and sustained release comprise particulate core and nifedipine coating |
| 09/07/2000 | DE19909770A1 Bakterienghosts als Träger- und Targetingvehikel Bacterial ghosts as carrier and targeting vehicles |
| 09/06/2000 | EP1033132A1 Rapidly soluble drug composition |
| 09/06/2000 | EP1033131A1 Composition of ingredients for a beverage having a delayed aversion effect |
| 09/06/2000 | EP1033128A2 Soft gelatin capsule manufacture |
| 09/06/2000 | EP1033127A1 Composition for forming solid particles |
| 09/06/2000 | EP1032647A1 Preservation of sensitive biological samples by vitrification |
| 09/06/2000 | EP1032605A1 Polyanhydrides with therapeutically useful degradation products |
| 09/06/2000 | EP1032592A1 Antimicrobial peptides |
| 09/06/2000 | EP1032426A1 Therapeutic agents |
| 09/06/2000 | EP1032425A1 Gellan gum tablet coating |
| 09/06/2000 | EP1032405A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 09/06/2000 | EP1032399A1 Progestin therapy with controlled bleeding |
| 09/06/2000 | EP1032398A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/06/2000 | EP1032396A1 New composition of matter |
| 09/06/2000 | EP1032392A1 Antihistamine/decongestant regimens for treating rhinitis |
| 09/06/2000 | EP1032391A1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
| 09/06/2000 | EP1032390A1 Anaesthetic formulation |
| 09/06/2000 | EP1032389A1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 09/06/2000 | EP1032379A1 Composition with azelaic acid |
| 09/06/2000 | EP1032378A1 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 09/06/2000 | EP1032374A1 Spheroids, preparation method and pharmaceutical compositions |
| 09/06/2000 | EP1032373A1 Drug delivery systems utilizing liquid crystal structures |
| 09/06/2000 | EP1032372A1 Masking agent in powder form for pharmaceutical flavours |
| 09/06/2000 | EP1032371A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
| 09/06/2000 | EP1032370A1 Porous hydroxyapatite particles as carriers for drug substances |
| 09/06/2000 | EP1032369A1 Targeted liposome gene delivery |
| 09/06/2000 | EP1032368A1 Iontophoretic devices comprising piperidin derivatives |
| 09/06/2000 | EP1032367A2 Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
| 09/06/2000 | EP0817612B1 Transparent rapid-release preparations of non-steroid analgesics |